Oncology Center Overview
Specialty Introduction: Fosun Health, represented by the Cancer Centers of Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital, has established a modern cancer prevention and treatment network integrating “Full-Cycle…
Departments
Oncology Center Overview
Specialty Introduction:
Fosun Health, represented by the Cancer Centers of Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital, has established a modern cancer prevention and treatment network integrating “Full-Cycle Management, One-Stop Service, and Precision Diagnosis.”
· Scale of Resources: Equipped with over 440 open beds and multiple specialized wards, the network possesses the capacity to admit and treat a large number of patients with diverse complex tumors.
· Clinical Model: The network fully implements the international-standard Multi-Disciplinary Team (MDT) model, integrating surgery, chemotherapy, and radiotherapy with cutting-edge technologies from around the world.
· State-of-the-Art Equipment: The network is equipped with advanced radiotherapy and minimally invasive interventional systems, including the CyberKnife M6 (one of only approximately 300 units worldwide) and the next-generation Varian VitalBeam linear accelerator.
· International Certification: The Oncology Center of Foshan Fosun Chancheng Hospital was the first in Asia to be certified as a member of the Radiosurgery Society (RSS) in 2021.
· National Patent: The center developed the original SCART (Stereotactic Centralized Ablative Radiation Therapy) technology, which has been granted a Chinese national patent.
· Regional Benchmark: The center is recognized as a “14th Five-Year Plan” Medical Key Specialty in Chancheng District, Foshan, and serves as the chairing institution of the Oncology Subcommittee of the Baiyun District Medical Association, Guangzhou.
Featured Treatment Programs:
Our signiture treatment programs include robotic surgery, precision radiotherapy, minimally invasive interventions, CAR-T cell therapy, and Tumor Treating Fields. Together, we provide one-stop, integrated oncology care that combines advanced medical technologies with personalized, patient-centered support seamlessly.
| Category | Disease Scope | Core Treatment Capabilities |
| Non-CNS Solid Tumors | Lung, breast, ovarian, endometrial, colorectal, gastric, esophageal, pancreatic, prostate, liver, thyroid, melanoma, ocular adnexal / intraocular tumors, bladder, bone and other solid tumors | - Surgery, including Da Vinci robotic surgery where appropriate - Radiotherapy, including Cyberknife and linear accelerator - Interventional therapy, including TACE and ablation, etc. - Endocrine therapy for hormone-sensitive tumors - Targeted therapy - Immunotherapy - Chemotherapy - Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for ovarian cancer - Integrated TCM therapy - Nutrition support - Pain management - Rehabilitation |
| Central Nervous System Tumors | Glioma and other CNS tumors | - Surgery - Radiotherapy, including Cyberknife and linear accelerator - Tumor treating fields (TTF) for selected glioblastoma patients - Chemotherapy - Targeted therapy for selected molecular subtypes - Immunotherapy in selected cases or clinical-trial settings, such as recurrent GBM - Anti-epileptic treatment - Integrated TCM therapy - Nutrition support |
| Hematologic Malignancies | Leukemia, lymphoma, multiple myeloma and other hematologic malignancies | - CAR-T cell therapy - Targeted therapy - Immunotherapy for selected types - Chemotherapy - Radiotherapy for selected localized disease - Integrated TCM therapy - Nutrition support |
Cheaper · Quicker · Better
Cheaper
Benefiting from China’s drug price policies and competitive pharmaceutical market, patients in China can often access leading oncology medicines at far more affordable prices. For example, based on public list prices, Tevimbra (tislelizumab) in China is priced at less than 5% of the U.S. list price.
Quicker
Patients in China may gain earlier access to selected China-developed immunotherapies, precision therapies targeting mutations more commonly seen in Asian patients, and next-generation ADCs.
In 2024, China-headquartered companies initiated 39%[Source: IQVIA] of global oncology clinical trials, ranking No.1 worldwide. Fosun Health provides access to China’s Phase III clinical trial resources for patients seeking options beyond standard treatment.
Better
Cancer treatment can be demanding. Our integrative TCM program complements primary oncology treatment and focuses on two evidence-based goals: reducing treatment-related toxicity and improving treatment tolerance.
Key Statistics
60,000+
Annual oncology patient admissions across our major international hospitals in 2025
17,000+
Cumulative TACE procedures performed at Guangzhou Fosun Chancheng Hospital alone from 2023 to 2025, with international patients accounting for more than 10% of the total
1,000+
Successful CyberKnife treatments performed, demonstrating world-class precision radiotherapy expertise
29.3%
Five-year survival rate achieved for patients with Glioblastoma Multiforme (GBM) receiving combined TTFields therapy, compared with the baseline of 4.7%
Core Medical Team:

Prof. Yang Jun
Director, Precision Oncology Center, Fosun Hospital Foshan
Co-author of the North American CyberKnife QA guideline, the North American Radiosurgery Physicist Practice Code, the North American Radiosurgery Physics White Paper, and the Chinese CyberKnife Quality Control Guidelines
Previous Board Director of the Radiosurgery Society (RSS)
Trained under globally renowned radiation oncology pioneers, he brings 20+ years of U.S. experience and 6,000+ CyberKnife procedures, bridging advanced research with clinical excellence.

Prof. Luo Pengfei
Founder of Minimally Invasive Tumor Interventional Therapy in China, International Patent Holder, Recipient of the Special Government Allowance from the State Council of China.
Fosun Hospital Guangzhou
He specializes in precise minimally invasive treatment for various solid tumors, with over 40 years of clinical experience. In October 2022, he established the “LuoPengfei Programmatic Tumor Inactivation Therapy (PTITM) ", which received international patent certification from the Government of Luxembourg.

Prof. Chen Tao
Member of the Clinical Chemotherapy Professional Committee of the China Anti-Cancer Association (CACA)
Member of the Hematological Oncology Translational Medicine Professional Committee of the China Anti-Cancer Association (CACA)
Fosun Hospital Guangzhou
He possesses 40 years of international clinical and research experience across China and the United States, specializing in chemotherapy, targeted therapy, and immunotherapy for hematological lymphomas and solid tumors. He won the U.S. Distinguished Contribution Award for Leukemia Research.

Prof. Zeng Zongyuan
Chief Physician, Recipient of the Special Government Allowance of the State Council of China, Guangzhou Fosun Chancheng Hospital
With over 60 years of experience in oncology research, Professor Zeng is a renowned expert in head and neck tumors, particularly laryngeal and oral cancers. He remains the Chief Expert for laryngeal cancer in Guangdong Province. Famous for his "Zero Bleeding" technique, he pioneered innovative suturing methods to prevent hemorrhage. He has achieved exceptional success in surgeries for thyroid tumors, parotid gland tumors, and facial/neck hemangiomas.

Prof. Ye Gang
Chief Physician
Member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematologists (ASH)
Chief Clinical Officer, Medical Oncology and Hematology
Fosun Hospital Foshan
Practicing oncology and hematology in China and the United States for 30+ years, with expertise in clinical practice, teaching, research and drug development, particularly in the field of lymphoma, multiple myeloma, as well as solid tumors such as breast cancer and lung cancer.

Prof. Zhou Zejian
Chief Physician
Fosun Hospital Guangzhou
He is one of the first physicians in China to practice interventional radiology. With nearly 40 years of experience, he specializes in minimally invasive interventional and comprehensive treatment for malignant tumors and non-malignant diseases, including arterial and venous stenosis or occlusion, hemangiomas, vascular malformations, varicocele, uterine fibroids, diabetic foot, cysts, abscesses, and other conditions.
Professor Zhou and his team perform an average of 10,000 procedures annually. Many patients have survived for more than 10 years after treatment, with some achieving survival of 20 to 30 years.

Prof. Han Liangfu
Chief Physician
Chief Medical Expert , Precision Oncology Center, Fosun Hospital Foshan
Dr. Han is a distinguished specialist in breast and prostate cancer. He honed his expertise in advanced radiotherapy techniques at Rush University Medical Center, USA. He specializes in precision radiotherapy and comprehensive cancer care.

Prof. Wang Enmin
Chief Physician
Chief Stereotactic Radiosurgery Specialist, Precision Oncology Center, Fosun Hospital Foshan
As China's first Gamma Knife Ph.D. (1996), Prof. Wang has performed over 10,000 Gamma Knife and 12,000 CyberKnife procedures. He specializes in radiosurgery for brain tumors (acoustic neuromas, meningiomas) and body cancers (lung/liver/pancreatic). He is editor of China's authoritative CyberKnife monograph and contributor to international standards.

Prof. Ye Sheng
Chief Physician, Guangzhou Fosun Chancheng Hospital
Professor Ye has more than 30 years of clinical experience in medical oncology and specializes in the comprehensive diagnosis and treatment of lung cancer, gastric cancer, colorectal cancer, and liver cancer.

Dr. Lu Qiuxia
Chief Physician
Medical Director, Precision Oncology Center, Fosun Hospital Foshan
Dr. Lu specializes in the comprehensive management of benign and malignant tumors, including precision radiotherapy, toxicity management, combined chemoradiotherapy, cellular immunotherapy and molecular-targeted therapy. She has extensive experience in the precision diagnosis and treatment of nasopharyngeal carcinoma, head-and-neck tumors, primary or metastatic intracranial malignancies and lung cancer.

Dr. Gong Wei
Senior Radiotherapy Expert and Director of Thoracic Specialty, Precision Oncology Center, Fosun Hospital Foshan
Proficient in the diagnosis and treatment of various malignant tumors, he excels in precision radiotherapy and comprehensive care, with extensive experience in radiotherapy, chemotherapy, and targeted therapy for common cancers such as lung, nasopharyngeal, esophageal, liver, and colorectal cancer.

Prof. Chen Bingguang
Chief Physician
Tumor Radiotherapy Expert, Precision Oncology Center, Fosun Hospital Foshan
Vice Chairman of the Chinese Colorectal Cancer MDT Alliance
With 29 years of medical practice, he excels in designing multidisciplinary treatment plans for digestive tumors like liver and colorectal cancer, as well as common solid malignancies.

Prof. Wang Jian
Chief Physician
Fosun Hospital Guangzhou
Specializes in the comprehensive application of radical surgical resection and minimally invasive interventional techniques for malignant tumors. His expertise includes transarterial chemoembolization (TACE), radioactive seed implantation, physical ablation, and stent implantation (vascular, esophageal, and biliary). He also specializes in treating portal hypertension, deep vein thrombosis (DVT), and esophageal/gastric varices.

Prof. Tang Rijie
Chief Physician/Doctoral Supervisor
Fosun Hospital Guangzhou
With over 40 years in clinical oncology and research, Professor Tang specializes in the precision treatment of advanced tumors. He holds unique insights into recurrent and metastatic malignancies and complex cases, including lung, liver, biliary, pancreatic, laryngeal, urogenital, breast, colorectal, gastric, and cervical cancers, as well as sarcomas and head and neck tumors.

Prof. Jia Yun
Chief Physician
Fosun Hospital Guangzhou
Specializes in systemic medical treatments—including chemotherapy, endocrine therapy, targeted therapy, and immunotherapy—for various malignancies, particularly lung, gastrointestinal, breast, head and neck, and urogenital cancers. She focuses on individualized precision therapy for complex malignancies through Multidisciplinary Team (MDT) integration of surgery, radiotherapy, intervention, hyperthermia, and Iodine-125 seed implantation.

Dr. Cui Zhe
Chief Physician
Fosun Hospital Guangzhou
Specializes in standardized minimally invasive comprehensive treatment for various benign and malignant tumors. His clinical focus includes liver cancer, lung cancer, pancreatic cancer, cholangiocarcinoma, and liver metastasis of colorectal cancer. He has been honored as a "Star of the Jilin Health System," a "Lingnan Famous Doctor," and a "South Guangdong Good Doctor."

Dr. Zhang Dongxing
Chief Physician
Fosun Hospital Guangzhou
With over 30 years of clinical experience in oncology, Dr. Zhang specializes in integrating minimally invasive techniques, precision medicine, and immunotherapy to customize personalized strategies for patients. He has extensive experience in complex cases of lung, esophageal, breast, gastric, liver, biliary, pancreatic, colorectal, bladder, and nasopharyngeal cancers, as well as brain tumors, utilizing innovative technologies like vascular intervention, cryoablation, microwave, and radiofrequency ablation.

Prof. Zhong Guanghua
Associate Chief Physician
Medical Oncology Expert, Precision Oncology Center, Fosun Hospital Foshan
As an Associate Professor at Guangdong University of Chinese Medicine, he specializes in standardized and individualized comprehensive (lung, liver, colorectal treatments for malignant tumors, breast, etc.), including immune-targeted therapy, and interventional therapy.

Dr. Peng Qirong
Associate Chief Physician
Fosun Hospital Guangzhou
Specializes in precision treatment for liver cancer and other malignancies using advanced minimally invasive technologies. His expertise covers Iodine-125 seed technology, arterial intervention, cryosurgery, microwave ablation, various biopsy techniques, esophageal/biliary stenting, whole-body hyperthermia, photodynamic therapy (PDT), biotechnology, and combined immune and targeted therapies.

Dr. Ou Xiaobing
Oncologist
Fosun Hospital Guangzhou
Specialize in oncology and peripheral vascular intervention with 8 years of experience. Skilled in interventional therapies for systemic tumors including liver cancer, lung diseases, head and neck tumors, gastrointestinal tumors, cervical cancer, breast diseases, prostate cancer, soft tissue malignant tumors, and vascular tumors. Proficient in the management of malignant pleural and peritoneal effusions and handling of postoperative complications. He has completed over 7,000 surgeries in total.
Oncology Center Overview
Specialty Introduction:
Fosun Health, represented by the Cancer Centers of Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital, has established a modern cancer prevention and treatment network integrating “Full-Cycle Management, One-Stop Service, and Precision Diagnosis.”
· Scale of Resources: Equipped with over 440 open beds and multiple specialized wards, the network possesses the capacity to admit and treat a large number of patients with diverse complex tumors.
· Clinical Model: The network fully implements the international-standard Multi-Disciplinary Team (MDT) model, integrating surgery, chemotherapy, and radiotherapy with cutting-edge technologies from around the world.
· State-of-the-Art Equipment: The network is equipped with advanced radiotherapy and minimally invasive interventional systems, including the CyberKnife M6 (one of only approximately 300 units worldwide) and the next-generation Varian VitalBeam linear accelerator.
· International Certification: The Oncology Center of Foshan Fosun Chancheng Hospital was the first in Asia to be certified as a member of the Radiosurgery Society (RSS) in 2021.
· National Patent: The center developed the original SCART (Stereotactic Centralized Ablative Radiation Therapy) technology, which has been granted a Chinese national patent.
· Regional Benchmark: The center is recognized as a “14th Five-Year Plan” Medical Key Specialty in Chancheng District, Foshan, and serves as the chairing institution of the Oncology Subcommittee of the Baiyun District Medical Association, Guangzhou.
Featured Treatment Programs:
Our signiture treatment programs include robotic surgery, precision radiotherapy, minimally invasive interventions, CAR-T cell therapy, and Tumor Treating Fields. Together, we provide one-stop, integrated oncology care that combines advanced medical technologies with personalized, patient-centered support seamlessly.
| Category | Disease Scope | Core Treatment Capabilities |
| Non-CNS Solid Tumors | Lung, breast, ovarian, endometrial, colorectal, gastric, esophageal, pancreatic, prostate, liver, thyroid, melanoma, ocular adnexal / intraocular tumors, bladder, bone and other solid tumors | - Surgery, including Da Vinci robotic surgery where appropriate - Radiotherapy, including Cyberknife and linear accelerator - Interventional therapy, including TACE and ablation, etc. - Endocrine therapy for hormone-sensitive tumors - Targeted therapy - Immunotherapy - Chemotherapy - Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for ovarian cancer - Integrated TCM therapy - Nutrition support - Pain management - Rehabilitation |
| Central Nervous System Tumors | Glioma and other CNS tumors | - Surgery - Radiotherapy, including Cyberknife and linear accelerator - Tumor treating fields (TTF) for selected glioblastoma patients - Chemotherapy - Targeted therapy for selected molecular subtypes - Immunotherapy in selected cases or clinical-trial settings, such as recurrent GBM - Anti-epileptic treatment - Integrated TCM therapy - Nutrition support |
| Hematologic Malignancies | Leukemia, lymphoma, multiple myeloma and other hematologic malignancies | - CAR-T cell therapy - Targeted therapy - Immunotherapy for selected types - Chemotherapy - Radiotherapy for selected localized disease - Integrated TCM therapy - Nutrition support |
Data Highlights
Cheaper:
Benefiting from China’s drug price policies and competitive pharmaceutical market, patients in China can often access leading oncology medicines at far more affordable prices. For example, based on public list prices, Tevimbra (tislelizumab) in China is priced at less than 5% of the U.S. list price.
Quicker:
Patients in China may gain earlier access to selected China-developed immunotherapies, precision therapies targeting mutations more commonly seen in Asian patients, and next-generation ADCs.
In 2024, China-headquartered companies initiated 39%[Source: IQVIA] of global oncology clinical trials, ranking No.1 worldwide. Fosun Health provides access to China’s Phase III clinical trial resources for patients seeking options beyond standard treatment.
Better:
Cancer treatment can be demanding. Our integrative TCM program complements primary oncology treatment and focuses on two evidence-based goals: reducing treatment-related toxicity and improving treatment tolerance.
60,000+ Annual oncology patient admissions across our major international hospitals in 2025
17,000+ Cumulative TACE procedures performed at Guangzhou Fosun Chancheng Hospital alone from 2023 to 2025, with international patients accounting for more than 10% of the total
1,000+ Successful CyberKnife treatments performed, demonstrating world-class precision radiotherapy expertise
29.3% Five-year survival rate achieved for patients with Glioblastoma Multiforme (GBM) receiving combined TTFields therapy, compared with the baseline of 4.7%
Core Medical Team:

Prof. Yang Jun
Director, Precision Oncology Center, Fosun Hospital Foshan
Co-author of the North American CyberKnife QA guideline, the North American Radiosurgery Physicist Practice Code, the North American Radiosurgery Physics White Paper, and the Chinese CyberKnife Quality Control Guidelines
Previous Board Director of the Radiosurgery Society (RSS)
Trained under globally renowned radiation oncology pioneers, he brings 20+ years of U.S. experience and 6,000+ CyberKnife procedures, bridging advanced research with clinical excellence.

Prof. Luo Pengfei
Founder of Minimally Invasive Tumor Interventional Therapy in China, International Patent Holder, Recipient of the Special Government Allowance from the State Council of China.
Fosun Hospital Guangzhou
He specializes in precise minimally invasive treatment for various solid tumors, with over 40 years of clinical experience. In October 2022, he established the “LuoPengfei Programmatic Tumor Inactivation Therapy (PTITM) ", which received international patent certification from the Government of Luxembourg.

Prof. Chen Tao
Member of the Clinical Chemotherapy Professional Committee of the China Anti-Cancer Association (CACA)
Member of the Hematological Oncology Translational Medicine Professional Committee of the China Anti-Cancer Association (CACA)
Fosun Hospital Guangzhou
He possesses 40 years of international clinical and research experience across China and the United States, specializing in chemotherapy, targeted therapy, and immunotherapy for hematological lymphomas and solid tumors. He won the U.S. Distinguished Contribution Award for Leukemia Research.

Prof. Zeng Zongyuan
Chief Physician, Recipient of the Special Government Allowance of the State Council of China, Guangzhou Fosun Chancheng Hospital
With over 60 years of experience in oncology research, Professor Zeng is a renowned expert in head and neck tumors, particularly laryngeal and oral cancers. He remains the Chief Expert for laryngeal cancer in Guangdong Province. Famous for his "Zero Bleeding" technique, he pioneered innovative suturing methods to prevent hemorrhage. He has achieved exceptional success in surgeries for thyroid tumors, parotid gland tumors, and facial/neck hemangiomas.

Prof. Ye Gang
Chief Physician
Member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematologists (ASH)
Chief Clinical Officer, Medical Oncology and Hematology
Fosun Hospital Foshan
Practicing oncology and hematology in China and the United States for 30+ years, with expertise in clinical practice, teaching, research and drug development, particularly in the field of lymphoma, multiple myeloma, as well as solid tumors such as breast cancer and lung cancer.

Prof. Zhou Zejian
Chief Physician
Fosun Hospital Guangzhou
He is one of the first physicians in China to practice interventional radiology. With nearly 40 years of experience, he specializes in minimally invasive interventional and comprehensive treatment for malignant tumors and non-malignant diseases, including arterial and venous stenosis or occlusion, hemangiomas, vascular malformations, varicocele, uterine fibroids, diabetic foot, cysts, abscesses, and other conditions.
Professor Zhou and his team perform an average of 10,000 procedures annually. Many patients have survived for more than 10 years after treatment, with some achieving survival of 20 to 30 years.

Prof. Han Liangfu
Chief Physician
Chief Medical Expert , Precision Oncology Center, Fosun Hospital Foshan
Dr. Han is a distinguished specialist in breast and prostate cancer. He honed his expertise in advanced radiotherapy techniques at Rush University Medical Center, USA. He specializes in precision radiotherapy and comprehensive cancer care.

Prof. Wang Enmin
Chief Physician
Chief Stereotactic Radiosurgery Specialist, Precision Oncology Center, Fosun Hospital Foshan
As China's first Gamma Knife Ph.D. (1996), Prof. Wang has performed over 10,000 Gamma Knife and 12,000 CyberKnife procedures. He specializes in radiosurgery for brain tumors (acoustic neuromas, meningiomas) and body cancers (lung/liver/pancreatic). He is editor of China's authoritative CyberKnife monograph and contributor to international standards.

Prof. Ye Sheng
Chief Physician, Guangzhou Fosun Chancheng Hospital
Professor Ye has more than 30 years of clinical experience in medical oncology and specializes in the comprehensive diagnosis and treatment of lung cancer, gastric cancer, colorectal cancer, and liver cancer.

Dr. Lu Qiuxia
Chief Physician
Medical Director, Precision Oncology Center, Fosun Hospital Foshan
Dr. Lu specializes in the comprehensive management of benign and malignant tumors, including precision radiotherapy, toxicity management, combined chemoradiotherapy, cellular immunotherapy and molecular-targeted therapy. She has extensive experience in the precision diagnosis and treatment of nasopharyngeal carcinoma, head-and-neck tumors, primary or metastatic intracranial malignancies and lung cancer.

Dr. Gong Wei
Senior Radiotherapy Expert and Director of Thoracic Specialty, Precision Oncology Center, Fosun Hospital Foshan
Proficient in the diagnosis and treatment of various malignant tumors, he excels in precision radiotherapy and comprehensive care, with extensive experience in radiotherapy, chemotherapy, and targeted therapy for common cancers such as lung, nasopharyngeal, esophageal, liver, and colorectal cancer.

Prof. Chen Bingguang
Chief Physician
Tumor Radiotherapy Expert, Precision Oncology Center, Fosun Hospital Foshan
Vice Chairman of the Chinese Colorectal Cancer MDT Alliance
With 29 years of medical practice, he excels in designing multidisciplinary treatment plans for digestive tumors like liver and colorectal cancer, as well as common solid malignancies.

Prof. Wang Jian
Chief Physician
Fosun Hospital Guangzhou
Specializes in the comprehensive application of radical surgical resection and minimally invasive interventional techniques for malignant tumors. His expertise includes transarterial chemoembolization (TACE), radioactive seed implantation, physical ablation, and stent implantation (vascular, esophageal, and biliary). He also specializes in treating portal hypertension, deep vein thrombosis (DVT), and esophageal/gastric varices.

Prof. Tang Rijie
Chief Physician/Doctoral Supervisor
Fosun Hospital Guangzhou
With over 40 years in clinical oncology and research, Professor Tang specializes in the precision treatment of advanced tumors. He holds unique insights into recurrent and metastatic malignancies and complex cases, including lung, liver, biliary, pancreatic, laryngeal, urogenital, breast, colorectal, gastric, and cervical cancers, as well as sarcomas and head and neck tumors.

Prof. Jia Yun
Chief Physician
Fosun Hospital Guangzhou
Specializes in systemic medical treatments—including chemotherapy, endocrine therapy, targeted therapy, and immunotherapy—for various malignancies, particularly lung, gastrointestinal, breast, head and neck, and urogenital cancers. She focuses on individualized precision therapy for complex malignancies through Multidisciplinary Team (MDT) integration of surgery, radiotherapy, intervention, hyperthermia, and Iodine-125 seed implantation.

Dr. Cui Zhe
Chief Physician
Fosun Hospital Guangzhou
Specializes in standardized minimally invasive comprehensive treatment for various benign and malignant tumors. His clinical focus includes liver cancer, lung cancer, pancreatic cancer, cholangiocarcinoma, and liver metastasis of colorectal cancer. He has been honored as a "Star of the Jilin Health System," a "Lingnan Famous Doctor," and a "South Guangdong Good Doctor."

Dr. Zhang Dongxing
Chief Physician
Fosun Hospital Guangzhou
With over 30 years of clinical experience in oncology, Dr. Zhang specializes in integrating minimally invasive techniques, precision medicine, and immunotherapy to customize personalized strategies for patients. He has extensive experience in complex cases of lung, esophageal, breast, gastric, liver, biliary, pancreatic, colorectal, bladder, and nasopharyngeal cancers, as well as brain tumors, utilizing innovative technologies like vascular intervention, cryoablation, microwave, and radiofrequency ablation.

Prof. Zhong Guanghua
Associate Chief Physician
Medical Oncology Expert, Precision Oncology Center, Fosun Hospital Foshan
As an Associate Professor at Guangdong University of Chinese Medicine, he specializes in standardized and individualized comprehensive (lung, liver, colorectal treatments for malignant tumors, breast, etc.), including immune-targeted therapy, and interventional therapy.

Dr. Peng Qirong
Associate Chief Physician
Fosun Hospital Guangzhou
Specializes in precision treatment for liver cancer and other malignancies using advanced minimally invasive technologies. His expertise covers Iodine-125 seed technology, arterial intervention, cryosurgery, microwave ablation, various biopsy techniques, esophageal/biliary stenting, whole-body hyperthermia, photodynamic therapy (PDT), biotechnology, and combined immune and targeted therapies.

Dr. Ou Xiaobing
Oncologist
Fosun Hospital Guangzhou
Specialize in oncology and peripheral vascular intervention with 8 years of experience. Skilled in interventional therapies for systemic tumors including liver cancer, lung diseases, head and neck tumors, gastrointestinal tumors, cervical cancer, breast diseases, prostate cancer, soft tissue malignant tumors, and vascular tumors. Proficient in the management of malignant pleural and peritoneal effusions and handling of postoperative complications. He has completed over 7,000 surgeries in total.
Choosing a Clinical Center in China
What are the Core Clinical Centers of Fosun Health?
Fosun Health operates 20 departments and specialty centers across its hospitals in China — Oncology Center, Orthopedics, Traditional Chinese Medicine, Cardiovascular Medicine, Reproductive Medicine, Women & Children's Department, Ophthalmology, Neurology, Hepatobiliary Surgery, Nephrology, Plastic Surgery, Rehabilitation Medicine, Wound Repair, Breast and Thyroid Surgery, Integrated Medicine for Chronic Diseases, Health Management, Brain, Urology, Medical Checkup Center and Intensive Care Medicine — supported by 76 provincial and municipal key specialties and 7 GCP-certified hospitals.
Which center should I choose for cancer treatment?
Start with the Oncology Center, anchored at Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital. It covers non-CNS solid tumors, central nervous system tumors, and hematologic malignancies, with 60,000+ annual oncology admissions across our major international hospitals in 2025.
What makes the Fosun Health Oncology Center world-class?
It combines full-cycle MDT care with CyberKnife M6 radiosurgery (one of only approximately 300 units worldwide, with 6,000+ cases performed at Foshan Chancheng), the Varian VitalBeam linear accelerator, Da Vinci robotic surgery, CAR-T cell therapy, and Tumor Treating Fields. The Oncology Center of Foshan Fosun Chancheng Hospital was the first in Asia to be certified by the Radiosurgery Society (RSS) in 2021.
How do I choose a center for non-cancer conditions?
Use the Departments menu on this page. Each department opens an on-page profile with its official specialty introduction and featured treatment programs. A link at the bottom of each profile leads to the full department page on hospitals.fosunhealth.com. If you are unsure, send us your reports for a free evaluation, and our specialists will recommend the appropriate center and doctor for your case.
Do these clinical centers accept international patients?
Yes. All departments serve international patients through our network-wide international patient teams, with multilingual support, direct billing with 70+ insurers, and access to 52 innovative international medicines and devices under the Hong Kong and Macau Drug and Device Access Policy at designated hospitals.
Can I get a second opinion before travelling to China?
Yes. Begin with a remote video consultation or medical record review through our 9 licensed internet hospitals. Specialists review your scans and records, recommend the appropriate center and doctor, and our international team coordinates scheduling, visa, and travel arrangements.
Find the Right Center for Your Condition
Send us your reports for a free review — our specialists will recommend the right clinical center and doctor for your case.
Book a Consultation Start with a Video Consultation Browse Conditions We Treat
